CNB Bank’s Zevra Therapeutics ZVRA Stock Holding History

CNB Bank’s Portfolio ZVRA Stock Details ZVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,938	Closed	-$15K	–	516
2023 Q2	$15K	Hold	2,938	–	–	0.01%	304
2023 Q1	$16.2K	Hold	2,938	–	–	0.01%	307
2022 Q4	$13.5K	Sell	2,938 -62	-2%	-$315	0.01%	307
2022 Q3	$19K	Hold	3,000	–	–	0.01%	282
2022 Q2	$13K	Hold	3,000	–	–	0.01%	308
2022 Q1	$15K	Hold	3,000	–	–	0.01%	309
2021 Q4	$26K	Hold	3,000	–	–	0.01%	268
2021 Q3	$28K	Hold	3,000	–	–	0.02%	270
2021 Q2	$38K	Hold	3,000	–	–	0.02%	248
2021 Q1	$28K	Buy	+3,000	New	+$26.2K	0.02%	268

Other funds holding ZVRA

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RPCONE

Retirement Planning Company of New England Warwick, Rhode Island $278M AUM 38.65% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

MAM

Mystic Asset Management Warwick, Rhode Island $468M AUM 30.94% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CNB Bank's ZVRA Position: Q3 2023 in Review

CNB Bank sold out of Zevra Therapeutics (ZVRA) in Q3 2023, closing a stake of 2,938 shares — an estimated $15K sold.

CNB Bank first reported a position in ZVRA in Q1 2021 and held it in 10 quarters. The position peaked at $38K in Q2 2021. 77 funds tracked by Wall St. Rank hold ZVRA as of Q3 2023.

CNB Bank reported no remaining Zevra Therapeutics position as of Q3 2023 after selling out during the quarter.
CNB Bank sold 2,938 Zevra Therapeutics shares in Q3 2023, an estimated $15K.
CNB Bank first reported a position in Zevra Therapeutics in Q1 2021 and held it in 10 quarters.
CNB Bank's Zevra Therapeutics position peaked at $38K in Q2 2021.
77 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q3 2023.

Based on CNB Bank's 13F filing for Q3 2023, filed 2 Nov 2023.